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Dosimetric Comparison of VMAT, IMRT and 
Proton Therapy for Post- Prostatectomy 
Radiation Therapy for Prostate Cancer
Purpose/Objectives
Radiation therapy (RT) for the treatment of prostate cancer after 
radical prostatectomy (RP) is widely accepted. With technological 
advances, radiation treatment technique and dosimetry may vary. 
The purpose of this study is to quantify dosimetric difference of 
proton therapy versus VMAT and IMRT focusing on bladder and 
rectal dose sparing and target coverage.
Materials/Methods
This study analyzes a subset of twenty patients who received post-RP 
RT at our institution and builds on initial work comparing 3DRT 
to IMRT for these patients. All volumes were delineated by a single 
observer in accordance with EORTC consensus guidelines. A CTV 
expansion of 7mm (5mm posteriorly) was used to determine the PTV. 
All plans met a minimum of 95% target coverage to a prescription 
dose of 68.4 Gy. Optimal beam arrangement for IMRT was previously 
studied at our institution, leading to selection of a 9-field technique. 
The VMAT planning utilized either 1 or 2 full arcs depending upon 
optimizer performance. The proton arrangement was opposed 
laterals and utilized active scanning. As this was a strict dosimetric 
analysis, density corrections were not employed. Five patients were 
analyzed for this initial study. Differences of DVH values between 
plans were evaluated using 2-tailed paired t-tests.
Results
Planning with all three treatment techniques demonstrated 
comparable PTV coverage. Difference in dose sparing of bladder 
or rectum between 9-field IMRT and VMAT planning was not 
significant. Improvement in rectal doses, proton versus VMAT and 
IMRT was significant when comparing V40Gy, V34.2Gy (28%, vs 48.16% 
and 45.33%, p=0.016 & p=0.0004). Bladder doses showed significance 
at V30Gy, V17.1Gy (32.58% vs 57.27% & 62.76%, p=0.045 & p=0.04). 
Differences for VD when D>40Gy for rectum and VD when D>30Gy 
for bladder across all planning techniques were not significant.
Conclusion
Proton planning resulted in greater sparing of normal tissues at lower 
doses with equivalent planned target coverage. Further research is 
necessary to determine the significance of better planned doses with 
protons compared to photon treatment with regard to toxicity and 
proven efficacy of photon therapy. The delivery efficiency with VMAT 
may prove a viable advantage. Cost effectiveness research is necessary 
to determine if the increased cost of proton therapy is outweighed by 
benefit to the patient if these dosimetric improvements translate into 
improved clinical outcomes for PC patients.
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